Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia

BACKGROUND/AIMS: Therapies of functional dyspepsia (FD) are limited. DA-9701 is a novel prokinetic agent formulated with Pharbitis semen and Corydalis Tuber. We aimed to assess the efficacy of DA-9701 compared with itopride in FD patients. METHODS: Patients with FD randomly received either itopride...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Myung-Gyu, Rhee, Poong-Lyul, Park, Hyojin, Lee, Oh Young, Lee, Kwang Jae, Choi, Suck Chei, Seol, Sang Young, Chun, Hoon Jai, Rew, Jong-Sun, Lee, Dong Ho, Song, Geun Am, Jung, Hwoon Yong, Jeong, Hyung Yong, Sung, In Kyung, Lee, Joon Seong, Lee, Soo Teik, Kim, Sung Kook, Shin, Yong Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496904/
https://www.ncbi.nlm.nih.gov/pubmed/26130637
http://dx.doi.org/10.5056/jnm14117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496904/
https://www.ncbi.nlm.nih.gov/pubmed/26130637
http://dx.doi.org/10.5056/jnm14117

Ejemplares similares